92 Results for "

phosphodiesterase-4

" in MedChemExpress (MCE) Product Catalog:
Products (92)

92 Results for "phosphodiesterase-4" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-117571
CAS No.: 1606974-33-7
Purity:  99.50%
Synonyms: BPN14770
Research Areas:  

Neurological Disease

Zatolmilast (BPN14770) is a selective phosphodiesterase 4D (PDE4D) allosteric inhibitor with IC50s of 7.8 nM and 7.4 nM for PDE4D7 and PDE4D3, respectively .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-122942
CAS No.: 56317-21-6
Purity:  98.90%
Moracin M is a phenolic component that can be isolated from Mori Cortex, is a potent phosphodiesterase-4 (PDE4) inhibitor with IC50 values of 2.9, 4.5, >40, and >100 μM for PDE4D2, PDE4B2, PDE5A1, and PDE9A2, respectively. Moracin M has anti-inflammatory activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-109085
CAS No.: 937782-05-3
Purity:  99.63%
Synonyms: OPA-15406
Difamilast (OPA-15406) is a topical, selective and nonsteroidal phosphodiesterase-4 (PDE4) inhibitor with particularly efficient inhibition of subtype B (IC50=11.2 nM). Difamilast can be used for the research of mild to moderate atopic dermatitis (AD) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-10790
CAS No.: 153259-65-5
Purity:  99.91%
Synonyms: SB-207499
Research Areas:  

Inflammation/Immunology

Cilomilast (SB-207499) is a potent, selective and orally active inhibitor of Phosphodiesterase 4 (PDE4), with IC50s of ~100 and 120 nM for LPDE4 and HPDE4, respectively. Cilomilast shows selectivity for PDE4 over PDE1, PDE2, PDE3 and PDE5 (IC50=74, 65, >100, and 83 μM, respectively). Cilomilast has anti-inflammatory and immunomodulatory effects and can be used for thr research of asthma and chronic obstructive pulmonary disease (COPD) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-10469
CAS No.: 801312-28-7
Purity:  98.69%
Research Areas:  

Inflammation/Immunology

GSK256066 is a selective and high-affinity phosphodiesterase 4 (PDE4) inhibitor, with an IC50 of 3.2 pM for PDE4B. GSK256066 is developed for the research of chronic obstructive pulmonary disease .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-128358
CAS No.: 2374703-19-0
Purity:  98.37%
Research Areas:  

Neurological Disease

MR-L2 is a reversible and noncompetitive allosteric activator of long-isoform phosphodiesterase-4 (PDE4), activates representative PDE4 long-isoform variants (PDE4A4, PDE4B1, PDE4C3, PDE4D5). MR-L2 suppresses PGE2-induced MDCK cell cyst formation with an EC50 of 1.2 μM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-70069
CAS No.: 1415560-64-3
Research Areas:  

Inflammation/Immunology

GSK256066 Trifluoroacetate is a selective and high-affinity phosphodiesterase 4 (PDE) inhibitor, with an IC50 of 3.2 pM for PDE4B. GSK256066 Trifluoroacetate is developed for the research of chronic obstructive pulmonary disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-134124
CAS No.: 92614-59-0
Purity:  95.8%
Research Areas:  

Metabolic Disease

Glutathione ethyl ester is a cell-permeable GSH donor and provides an efficient supply of GSH to the oocyte. Glutathione ethyl ester shows positive effect on the in vitro production of embryos by enhancement of the antioxidative defense .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100438
CAS No.: 851518-71-3
Purity:  99.92%
Hydronidone is an orally active pyridine derivative. Hydronidone is an inhibitor of phosphodiesterase-4 (PDE4) and cyclo-oxygenase (COX) as well as TGF-β. Hydronidone induces mitochondrial dysfunction and triggers apoptosis. Hydronidone can be used for liver fibrosis, anti-inflammation and anti-cancer study .
loading...
    loading...
Cat. No.: HY-12887
CAS No.: 144035-83-6
Purity:  99.74%
Synonyms: RP 73401; RPR 73401
Research Areas:  

Inflammation/Immunology Cancer

Piclamilast (RP 73401) is a phosphodiesterase 4 (PDE4) inhibitor, with IC50 values of 16 nM and 2 nM in pig aorta and eosinophil soluble, respectively [4].
loading...
    loading...
Cat. No.: HY-145583
CAS No.: 1255909-03-5
Purity:  99.67%
Synonyms: Hemay005
Mufemilast (Heymay005) is a selective and orally active phosphodiesterase 4 (PDE4) inhibitor (IC50 = 80-120 nM). Mufemilast modulates cytokines upregulated in Behςet’s syndrome (BS). Mufemilast displays a significant inhibitory effect on TNF-α, which is an important proinflammatory cytokine target in the disease process of psoriasis. Mufemilast can be studied in research for diseases such as rheumatoid arthritis, psoriasis and BS [4] .
loading...
    loading...
Cat. No.: HY-19929
CAS No.: 1239278-59-1
Synonyms: CHF-6001
Tanimilast (CHF-6001) is an orally active and selective phosphodiesterase 4 inhibitor (IC50=0.026 nM) with robust anti-inflammatory activity and suitable for topical pulmonary administration. Tanimilast increases cellular cAMP levels, and inhibits NF-κB signaling pathway. Tanimilast is used for the research of obstructive lung diseases .
loading...
    loading...
Cat. No.: HY-N3945
CAS No.: 475-81-0
Synonyms: O,O-Dimethylisoboldine; S-(+)-Glaucine; NSC 34396
Glaucine (O,O-Dimethylisoboldine) is an alkaloid extracted from Glaucium flavum that possesses various activities, including cough relief, bronchodilation, anti-inflammatory effects, analgesia, antipyretic properties, and anticancer effects. Glaucine acts as a selective and orally active inhibitor of phosphodiesterase 4 (PDE4), with a Ki of 3.4 µM in human bronchial tissues and polymorphonuclear leukocytes. Glaucine induces relaxation of human isolated bronchi by antagonizing calcium channels. Additionally, Glaucine inhibits the activation of NF-κB, leading to a reduction in the expression of the MMP-9 gene, thereby suppressing the migration and invasion of breast cancer cells. Therefore, Glaucine holds potential for research in asthma and breast cancer [4] .
loading...
    loading...
Cat. No.: HY-147263
CAS No.: 340019-69-4
Purity:  99.83%
Synonyms: CC-11050
Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor and can reduce the inflammatory response and improves Isoniazid (HY-B0329)-mediated bacillary clearance from the lungs. Dovramilast, as an adjunct, is used for the research of tuberculosis (TB) .
loading...
    loading...
Cat. No.: HY-15178
CAS No.: 778576-62-8
Purity:  98.00%
Synonyms: GRC 3886
Research Areas:  

Inflammation/Immunology

Oglemilast (GRC 3886) is a potent and orally active phosphodiesterase-4 (PDE4) inhibitor with an IC50 of 0.5 nM for PDE4D3. Oglemilast inhibits pulmonary cell infiltration, including eosinophilia and neutrophilia in vitro and in vivo. Oglemilast has the potential for inflammatory airway diseases .
loading...
    loading...
Cat. No.: HY-101803
CAS No.: 445295-04-5
Purity:  99.95%
Research Areas:  

Others

CP671305 is a potent, orally active, selective inhibitor of phosphodiesterase-4-D, and possesses high activities.
loading...
    loading...
Cat. No.: HY-B0392
CAS No.: 85416-73-5
Synonyms: (+)-Rolipram; (S)-Rolipram
(S)-(+)-Rolipram ((+)-Rolipram) is a cyclic AMP(cAMP)-specific phosphodiesterase 4 (PDE4) inhibitor, with an IC50 of 1100 nM. (S)-(+)-Rolipram can suppresse tumor necrosis factor-alpha (TNFα) production by human mononuclear cells .
loading...
    loading...
Cat. No.: HY-101762
CAS No.: 2098466-94-3
Purity:  98.64%
Research Areas:  

Inflammation/Immunology

TyK2-IN-2 (Compoud 18) is a potent and selective TYK2 inhibitor with IC50s of 7 nM, 0.1 μM and 0.05 μM for TYK2 JH2, IL-23 and IFNα, respectively. TyK2-IN-2 also inhibits phosphodiesterase 4 (PDE4) with an IC50 of 62 nM. TyK2-IN-2 can be used for the research of inflammatory and autoimmune diseases .
loading...
    loading...
Cat. No.: HY-108617
CAS No.: 191219-80-4
Purity:  ≥99.0%
Research Areas:  

Inflammation/Immunology

YM976 is a phosphodiesterase 4 (PDE4) inhibitor with an IC50 of 2.2 nM. YM976 shows the dissociation of anti-inflammatory activities from emetic effects and inhibits the antigen-induced airway responses .
loading...
    loading...
Cat. No.: HY-108047
CAS No.: 500355-52-2
MK-0873 is a selective phosphodiesterase-4 (PDE4) inhibitor with an IC50 value of < 38 nM. MK-0873 inhibits LPS-induced TNF-α production. MK-0873 suppresses bronchoconstriction. MK-0873 is applicable to research related to chronic obstructive pulmonary disease, plaque psoriasis and asthma .
loading...
    loading...